Low Expression of LncRNA Cancer Susceptibility Candidate 2 and its Clinical Significance in Cancer Tissues

Background/Aims: Long noncoding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2) is downregulated in various cancers and involved in both tumorigenesis and progression. The aim of this study was to assess the prognostic value of lncRNA CASC2 in cancer patients. Methods: We searched the Web of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cellular Physiology and Biochemistry 2018-05, Vol.46 (4), p.1643-1649
Hauptverfasser:	Zhu, Zheng-ming, Liu, Fang-teng, Chen, Xuan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Cancer patients Cancer susceptibility candidate 2 Care and treatment Cell growth Cell Line, Tumor Cervical cancer Clinical significance Databases, Factual Disease susceptibility Down-Regulation Esophagus Gastric cancer Genetic aspects Health aspects Humans Liver cancer Long noncoding RNA Lung cancer Medical prognosis Meta-analysis Multivariate analysis Neoplasm Staging Neoplasms - metabolism Neoplasms - mortality Neoplasms - pathology Odds Ratio Original Paper Overall survival Pancreatic cancer Prognosis Proportional Hazards Models Risk factors RNA RNA, Long Noncoding - genetics RNA, Long Noncoding - metabolism Survival Rate Thyroid cancer Tumor stage Tumor Suppressor Proteins - genetics Tumorigenesis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!